HBM-7026

N/A

Report date: 2026/03/19 17:11:47

Base Information

Drug NameHBM-7026

Drug Alias NameHBM7026HBM-7026

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibodyBiologics > T cell engagers

Mechanisms of ActionAnti-CD3Anti-CD19Anti-BCMA

TargetsT cell surface glycoprotein CD3B-lymphocyte antigen CD19B-cell maturation protein

Therapy Area/IndicationsAutoimmune Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesHarbour Biomed

China Registration ClassN/A

Develop Information

Active CompaniesHarbour Biomed

Inactive CompaniesN/A

Active IndicationsAutoimmune Diseases

Inactive IndicationsN/A

Other Information

ATC CodeN/A